logo
Metropolis Healthcare completes acquisition of Dr. Ahujas' Pathology & Imaging Centre

Metropolis Healthcare completes acquisition of Dr. Ahujas' Pathology & Imaging Centre

Dapic Metropolis Healthcare (formerly known as Metropolis Histoxpert Digital Services), a wholly owned subsidiary of Metropolis Healthcare, has completed the acquisition of entire business of Dr. Ahujas' Pathology & Imaging Centre (DAPIC a partnership firm), Dr. Alok Ahuja and Dr. Alka Ahuja (collectively referred to as acquired business) as a going-concern, effective 23 May 2025, in accordance with the terms agreed under the Business Transfer Agreement.
Following the completion of the acquisition, the operations of the acquired business are now being carried out under Dapic Metropolis Healthcare effective 23 May 2025.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Technical Breakout: Metropolis Healthcare Poised for Rally, Says SMC Global's Shitij Gandhi
Technical Breakout: Metropolis Healthcare Poised for Rally, Says SMC Global's Shitij Gandhi

Economic Times

time09-07-2025

  • Economic Times

Technical Breakout: Metropolis Healthcare Poised for Rally, Says SMC Global's Shitij Gandhi

'Metropolis Healthcare has broken out decisively above a key resistance level following an extended consolidation phase. Traders can buy the stock for a target of Rs 2070 in the next 1-2 months,' Shitij Gandhi, Senior Technical Analyst, SMC Global Securities, said Show more 06:05 01:47 02:06 04:55 01:18 01:44 04:45 02:03 04:15 04:31 01:45 05:31 01:41 04:39 01:57 04:01 01:25 05:12 06:51 02:03 01:33 01:39 04:18 05:40 04:05 01:34 06:58 02:15 05:13 05:49 04:16 06:46 07:02 02:22 01:20 05:13 04:31 02:05 02:05 04:06

Luma Fertility raises $4 mn in seed funding led by Peak XV's Surge
Luma Fertility raises $4 mn in seed funding led by Peak XV's Surge

Business Standard

time03-07-2025

  • Business Standard

Luma Fertility raises $4 mn in seed funding led by Peak XV's Surge

Mumbai-based fertility health-tech startup Luma Fertility has raised $4 million in seed funding, led by Peak XV's Surge, with participation from Ameera Shah (Metropolis Healthcare) and Vijay Taparia (B2V Ventures). The funding will help Luma expand its footprint in Mumbai and later scale into subsequent cities over the next two years. Ameera Shah, promoter and executive chairperson of Metropolis Healthcare, said, 'Fertility care in India is at an inflection point. Demand is growing rapidly, but the system is deeply fragmented and outdated. Patients are forced to navigate a maze of clinics, labs, and specialists with little coordination or support.' Founded by Neha K. Motwani, Luma Fertility's 6,000-square-foot facility houses a lab and offers comprehensive in-house fertility procedures. Luma is the first IVF clinic to launch an integrated app, allowing patients to track their treatment, access reports, and stay informed. Its AI-enabled tool, LumaAI, offers 24/7, jargon-free support on everything from cycle timelines to medication guidance. The global fertility services market is projected to reach $53 billion by 2030, driven by factors such as delayed parenthood, increasing age-related infertility, and declining global fertility rates. In India, the total fertility rate is at a historic low, declining from 2.1 to 1.9 births per woman. Over 33 million couples in the country face fertility challenges, with IVF cycles expected to grow from 320,000 in 2024 to 550,000 by 2028. As India's economy evolves and per capita income rises, there is significant latent demand for transparent, patient-centric, and tech-enabled fertility solutions, including egg and embryo freezing.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store